TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination. Chandler BC, Moubadder L, Ritter CL, Liu M, et al. J Clin Invest 2020 Jan 21. pii: 130435. doi: 10.1172/JCI130435.

Read + Share

Amedeo Smart

Independent Medical Education

Chandler BC, Moubadder L, Ritter CL, Liu M, et al. TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination. J Clin Invest 2020 Jan 21. pii: 130435. doi: 10.1172/JCI130435.
PMID: 31961339